A Vaccine Integrity Project review found influenza, COVID-19, and RSV immunizations continue to protect against severe illness, hospitalization, and death.
News|Slideshows|December 8, 2021
Flu Takes Backseat to COVID-19: Survey of US Adults
Author(s)Grace Halsey
Getting sick with COVID-19 is more worrisome to US adults than contracting the flu, the NFID found. How will that impact uptake of the flu shot this season?
Advertisement
Infection with influenza concerns a smaller proportion of US adults than contracting COVID-19, according to a
More attitudes, beliefs, and potential behaviors around
Advertisement
Related to this article
Catch up on the 9 FDA drug approvals most relevant to primary care, including new options for HIV-1 infection, narcolepsy, diabetes, pain management, and more.
FDA approved Pfizer-BioNTech’s XFG-adapted COMIRNATY formula for adults 65 and older and high-risk people aged 5 to 64 years.
Pre-existing antibodies to common microbes predicted COVID-19 vaccine response strength in healthy and immunosuppressed adults.
FDA approved bictegravir/lenacapavir for adults with suppressed HIV-1 and no known or suspected component resistance.
FDA expands dolutegravir dispersible tablets to children with HIV-1 weighing at least 2 kg, including eligible term newborns.
FDA has granted IDE approval for the STROKE-REWIRE pivotal trial evaluating NeuWire Medical's neurostimulation device for chronic ischemic stroke recovery.
EASD 2026: Oral semaglutide users lost 4.1% of body weight 3 months after switching from injections in an observational study without a comparator group.
Advertisement
Advertisement
Trending on Patient Care Online
1
HIV Testing Before and During PrEP: Getting It Right
2
9 Drugs Approved for Primary Care: Q3 2026
3
Immunizing Against Pain and Fear: Rethinking the Vaccination Experience
4
Starting the HIV PrEP Conversation in Primary Care and Pharmacy
5